BioCentury
ARTICLE | Management Tracks

Mike Johnson named Infinant CEO 

Plus CFO and COO to depart Avita and updates from Tallac and Outlook

January 21, 2023 1:12 AM UTC

Mike Johnson became CEO at Infinant Health Inc., a gut microbiome company formerly known as Evolve Biosystems. Johnson was global managing director at the animal health technologies division of Cargill Inc., before joining the board at Infinant. 

Tallac Therapeutics Inc. hired Kevin Heller as CMO, as the company prepares to take TAC-001, its TLR9 agonist conjugated to an antibody against CD22, into the clinic. Heller was EVP of R&D at Jasper Therapeutics Inc. (NASDAQ:JSPR), and CMO at NextCure Inc. (NASDAQ:NXTC)...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article